Ontology highlight
ABSTRACT:
INSTRUMENT(S): Q Exactive
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Melanocyte, Cell Culture
DISEASE(S): Melanoma
SUBMITTER: Shelly Kalaora
LAB HEAD: Yardena Samuels
PROVIDER: PXD015957 | Pride | 2020-02-18
REPOSITORIES: Pride
Action | DRS | |||
---|---|---|---|---|
108T_EV1.raw | Raw | |||
108T_EV2.raw | Raw | |||
108T_EV3.raw | Raw | |||
108T_IFN1.raw | Raw | |||
108T_IFN2.raw | Raw |
Items per page: 5 1 - 5 of 36 |
Kalaora Shelly S Lee Joo Sang JS Barnea Eilon E Levy Ronen R Greenberg Polina P Alon Michal M Yagel Gal G Bar Eli Gitit G Oren Roni R Peri Aviyah A Patkar Sushant S Bitton Lital L Rosenberg Steven A SA Lotem Michal M Levin Yishai Y Admon Arie A Ruppin Eytan E Samuels Yardena Y
Nature communications 20200214 1
Predicting the outcome of immunotherapy treatment in melanoma patients is challenging. Alterations in genes involved in antigen presentation and the interferon gamma (IFNγ) pathway play an important role in the immune response to tumors. We describe here that the overexpression of PSMB8 and PSMB9, two major components of the immunoproteasome, is predictive of better survival and improved response to immune-checkpoint inhibitors of melanoma patients. We study the mechanism underlying this connect ...[more]